Morgan Stanley
NTBL

Morgan Stanley’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Morgan Stanley’s Portfolio NTBL Stock Details NTBL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-800
Closed -$344 – 8207
2024
Q3 		$344 Buy
800
+300
+60% +$166 ﹤0.01% 7339
2024
Q2 		$314 Sell
500
-18,843
-97% -$19.2K ﹤0.01% 7269
2024
Q1 		$34.2K Sell
19,343
-26,721
-58% -$37K ﹤0.01% 6346
2023
Q4 		$87.1K Buy
46,064
+40,032
+664% +$158K ﹤0.01% 6210
2023
Q3 		$51.6K Sell
6,032
-3,311
-35% -$29K ﹤0.01% 6154
2023
Q2 		$75.2K Sell
9,343
-2,343
-20% -$17K ﹤0.01% 6060
2023
Q1 		$68.5K Sell
11,686
-589
-5% -$3.15K ﹤0.01% 6154
2022
Q4 		$51.6K Buy
12,275
+1,478
+14% +$6.95K ﹤0.01% 6279
2022
Q3 		$59K Sell
10,797
-6,346
-37% -$121K ﹤0.01% 6337
2022
Q2 		$966K Sell
17,143
-446
-3% -$24.4K ﹤0.01% 5036
2022
Q1 		$1.04M Sell
17,589
-794
-4% -$40.4K ﹤0.01% 4965
2021
Q4 		$1.27M Sell
18,383
-937
-5% -$72.2K ﹤0.01% 4907
2021
Q3 		$1.39M Sell
19,320
-492
-2% -$38.4K ﹤0.01% 4838
2021
Q2 		$1.66M Sell
19,812
-879
-4% -$66.6K ﹤0.01% 4773
2021
Q1 		$1.45M Sell
20,691
-1,531
-7% -$120K ﹤0.01% 4495
2020
Q4 		$1.47M Sell
22,222
-1,187
-5% -$56.8K ﹤0.01% 4407
2020
Q3 		$1M Sell
23,409
-7,821
-25% -$345K ﹤0.01% 4214
2020
Q2 		$1.4M Buy
31,230
+20,511
+191% +$925K ﹤0.01% 3908
2020
Q1 		$506K Buy
10,719
+375
+4% +$17.7K ﹤0.01% 4361
2019
Q4 		$434K Buy
10,344
+1,198
+13% +$51.8K ﹤0.01% 5004
2019
Q3 		$432K Buy
9,146
+717
+9% +$31.6K ﹤0.01% 4749
2019
Q2 		$383K Buy
8,429
+512
+6% +$23.3K ﹤0.01% 4739
2019
Q1 		$421K Buy
7,917
+1,301
+20% +$63.7K ﹤0.01% 4655
2018
Q4 		$224K Buy
6,616
+3,886
+142% +$171K ﹤0.01% 5234
2018
Q3 		$155K Buy
2,730
+2,057
+306% +$130K ﹤0.01% 5549
2018
Q2 		$51K Buy
673
+143
+27% +$11.5K ﹤0.01% 5915
2018
Q1 		$43K Buy
530
+325
+159% +$65.5K ﹤0.01% 5921
2017
Q4 		$51K Sell
205
-1,703
-89% -$396K ﹤0.01% 5836
2017
Q3 		$407K Buy
1,908
+265
+16% +$45.3K ﹤0.01% 5001
2017
Q2 		$256K Buy
1,643
+1,488
+960% +$281K ﹤0.01% 5202
2017
Q1 		$30K Buy
155
+112
+260% +$21.5K ﹤0.01% 5972
2016
Q4 		$7K Buy
+43
New +$7.46K ﹤0.01% 6233
2016
Q3 		– Sell
-952
Closed -$154K – 6579
2016
Q2 		$154K Buy
952
+889
+1,411% +$115K ﹤0.01% 5055
2016
Q1 		$8K Sell
63
-895
-93% -$108K ﹤0.01% 6185
2015
Q4 		$176K Buy
958
+955
+31,833% +$201K ﹤0.01% 5152
2015
Q3 		$1K Buy
+3
New +$647 ﹤0.01% 6554
2015
Q2 		– Sell
-169
Closed -$31K – 6775
2015
Q1 		$31K Buy
+169
New +$49.8K ﹤0.01% 5946

Morgan Stanley's NTBL Position: Q4 2024 in Review

Morgan Stanley sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q4 2024, closing a stake of 800 shares — an estimated $344 sold.

Morgan Stanley first reported a position in NTBL in Q1 2015 and held it in 37 quarters. The position peaked at $1.66M in Q2 2021. 0 funds tracked by Wall St. Rank hold NTBL as of Q4 2024.

  • Morgan Stanley reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q4 2024 after selling out during the quarter.
  • Morgan Stanley sold 800 Notable Labs, Ltd. Ordinary Shares shares in Q4 2024, an estimated $344.
  • Morgan Stanley first reported a position in Notable Labs, Ltd. Ordinary Shares in Q1 2015 and held it in 37 quarters.
  • Morgan Stanley's Notable Labs, Ltd. Ordinary Shares position peaked at $1.66M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q4 2024.

Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.